InvestorsHub Logo
Followers 12
Posts 2176
Boards Moderated 0
Alias Born 03/17/2010

Re: flipper44 post# 3110

Monday, 12/30/2013 2:13:41 PM

Monday, December 30, 2013 2:13:41 PM

Post# of 704380
I also thank you for the link, Flipper. I don't quite get what you're saying about DCVax-Direct and DCVax-L, with the live vs dead tumor comparison.

Are you thinking that because DCVax-Direct doesn't have a fixed set of cancer biomarkers at the time it is injected into the patient, that it will automatically adapt to any additional mutations the cancer has? Whereas DCVax-L will only attack the cancer as it existed at the time of the surgery?

If that is the case, are you saying that you expect the human results for DCVax-Direct to potentially match the preclinical results?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News